n-acetyltalosaminuronic acid has been researched along with Carcinoma, Pancreatic Ductal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burkhart, RA; Burns, WR; Cameron, JL; Delitto, DJ; Habib, JR; He, J; Ivey, GD; Kinny-Köster, B; Lafaro, KJ; Narang, A; Shoucair, S; Shubert, CR; Thompson, EL; Wolfgang, CL; Zheng, L | 1 |
1 other study(ies) available for n-acetyltalosaminuronic acid and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Postoperative Chemotherapy is Associated with Improved Survival in Patients with Node-Positive Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Humans; Neoadjuvant Therapy; Pancreatectomy; Pancreatic Neoplasms; Retrospective Studies; Uronic Acids | 2022 |